Literature DB >> 32743894

Characteristics of initial symptoms and symptoms at diagnosis in probable dementia with Lewy body disease: incidence of symptoms and gender differences.

Kumiko Utsumi1, Ryo Fukatsu2, Ritsuko Yamada3, Yuji Takamaru4, Yuko Hara2, Shuichi Yasumura5.   

Abstract

AIM: Although dementia with Lewy bodies (DLB) is characterized by a variety of initial symptoms, there are almost no reports of the initial symptoms of DLB assessed in a large number of cases. We retrospectively evaluated the initial symptoms of 234 participants with DLB and DLB-related symptoms at diagnosis and characterized any gender differences in the symptom profiles.
METHODS: This study consisted of 234 participants with probable DLB who met the diagnostic criteria outlined in the Fourth Consensus Report of the DLB Consortium (2017). DLB was confirmed based on several characteristic biomarkers for dopamine transporter imaging with 123 I-N-omega-fluoropropyl-2-beta-carbomethoxy-3-beta (4-iodophenyl) nortropane single-photon emission computed tomography, 123 I-metaiodobenzylguanidine myocardial scintigraphy, and brain perfusion measured with single photon emission computed tomography. In addition, core and supportive clinical features were considered in the diagnosis.
RESULTS: Initial symptoms included cognitive impairment (41.9%) and psychiatric symptoms (i.e. visual and auditory hallucinations, delusions, and depression) (42.3%). Almost half of the women initially presented with psychiatric symptoms, with significantly more women than men presenting with auditory hallucinations. In contrast, men had a significantly higher rate of rapid eye movement sleep behaviour disorder (RBD) than women did. At diagnosis, DLB-related symptoms differed between men and women, with male patients exhibiting significantly more RBD, parkinsonism, hyposmia, and syncope than female patients. Moreover women presented significantly more often with auditory hallucinations than did men.
CONCLUSIONS: Our results indicate that there are gender differences in the initial symptoms of DLB, as well as in the presentation of subsequent symptoms observed at diagnosis. There was a higher incidence of RBD in men, whereas women had a higher incidence of psychotic symptoms.
© 2020 Japanese Psychogeriatric Society.

Entities:  

Keywords:  dementia with Lewy bodies; gender differences; initial symptoms; symptom profiles

Mesh:

Substances:

Year:  2020        PMID: 32743894     DOI: 10.1111/psyg.12586

Source DB:  PubMed          Journal:  Psychogeriatrics        ISSN: 1346-3500            Impact factor:   2.440


  10 in total

1.  Clinical characteristics of Lewy body dementia in Chinese memory clinics.

Authors:  Jinghuan Gan; Shuai Liu; Xiaodan Wang; Zhihong Shi; Lu Shen; Xudong Li; Qihao Guo; Junliang Yuan; Nan Zhang; Yong You; Yang Lv; Dongming Zheng; Yong Ji
Journal:  BMC Neurol       Date:  2021-03-31       Impact factor: 2.474

Review 2.  Locus Coeruleus Malfunction Is Linked to Psychopathology in Prodromal Dementia With Lewy Bodies.

Authors:  Niels Hansen
Journal:  Front Aging Neurosci       Date:  2021-03-01       Impact factor: 5.750

3.  Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap.

Authors:  Silvia Morbelli; Silvia Chiola; Maria Isabella Donegani; Dario Arnaldi; Matteo Pardini; Raffaele Mancini; Francesco Lanfranchi; Francesca D'amico; Matteo Bauckneht; Alberto Miceli; Erica Biassoni; Beatrice Orso; Emanuela Barisione; Luana Benedetti; Sambuceti Gianmario; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-05       Impact factor: 10.057

4.  The temporal onset of the core features in dementia with Lewy bodies.

Authors:  Parichita Choudhury; Jonathan Graff-Radford; Jeremiah A Aakre; Lincoln Wurtz; David S Knopman; Neill R Graff-Radford; Kejal Kantarci; Leah K Forsberg; Julie A Fields; Otto Pedraza; Qin Chen; Toji Miyagawa; Gregory S Day; Philip Tipton; Rodolfo Savica; Hugo Botha; Christian Lachner; Brynn Dredla; R Ross Reichard; Ronald C Petersen; Dennis W Dickson; Bradley F Boeve; Tanis J Ferman
Journal:  Alzheimers Dement       Date:  2021-11-11       Impact factor: 16.655

5.  Sex differences in clinical cognitive impairment with Lewy bodies: a Chinese multicenter study.

Authors:  Jinghuan Gan; Zhichao Chen; Zhihong Shi; Xudong Li; Shuai Liu; Yiming Liu; Hongcan Zhu; Lu Shen; Guili Zhang; Yong You; Qihao Guo; Nan Zhang; Yang Lv; Baozhi Gang; Junliang Yuan; Yong Ji
Journal:  Biol Sex Differ       Date:  2022-10-01       Impact factor: 8.811

6.  Characteristics of very late-onset schizophrenia-like psychosis as prodromal dementia with Lewy bodies: a cross-sectional study.

Authors:  Hideki Kanemoto; Yuto Satake; Takashi Suehiro; Daiki Taomoto; Fuyuki Koizumi; Shunsuke Sato; Tamiki Wada; Keiko Matsunaga; Eku Shimosegawa; Mamoru Hashimoto; Kenji Yoshiyama; Manabu Ikeda
Journal:  Alzheimers Res Ther       Date:  2022-09-22       Impact factor: 8.823

7.  Sex differences for phenotype in pathologically defined dementia with Lewy bodies.

Authors:  Ece Bayram; David G Coughlin; Sarah J Banks; Irene Litvan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-02-09       Impact factor: 10.154

8.  Catatonia as the Initial Manifestation of Dementia with Lewy Bodies.

Authors:  Yusuke Saito; Keisuke Noto; Ryota Kobayashi; Akihito Suzuki; Daichi Morioka; Hiroshi Hayashi; Koichi Otani
Journal:  Am J Case Rep       Date:  2021-07-07

9.  Factors associated with the decision to prescribe and administer antipsychotics for older people with delirium: a qualitative descriptive study.

Authors:  Emily J Tomlinson; Helen Rawson; Elizabeth Manias; Nicole Nikki M Phillips; Peteris Darzins; Alison M Hutchinson
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692

10.  Assessing Nigrostriatal Dopaminergic Pathways via 123I-FP-CIT SPECT in Dementia With Lewy Bodies in a Psychiatric Patient Cohort.

Authors:  Niels Hansen; Claudia Lange; Charles Timäus; Jens Wiltfang; Caroline Bouter
Journal:  Front Aging Neurosci       Date:  2021-06-21       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.